Spina bifida is a birth defect when there is improper formation of the spine and spinal cord resulting in symptoms, such as weakness of the lower limbs, urinary and bowel incontinence, poor skin sensation, swelling at the site of spine, build-up of cerebrospinal fluid and others. The global Spina Bifida market is expected to surge owing to growing awareness, healthcare expenditure, and the growing success rate of medical intervention. Spina Bifida perceives a massive demand owing to growing number and reach of hospitals and healthcare infrastructure. Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/5643 As Market Research Future (MRFR) opines, the global Spina Bifida market is expected to register a CAGR of over 8.0% over the assessment period (2016-2027). Growing demand for treatment and the emergence of compulsory screening is a key driving force behind the substantial market demand. Spina Bifida affects about 15% of people in the world and has an average rate of 0.4 to 1.2 per 1000 births, which drives a consistent demand for treatment. The development of advanced shunts is driving a large market. The development of ope...